dsdsa

mankhwala

High Purity 540737-29-9 Tofacitinib citrate ya JAK Pathway Inhibitor

Kufotokozera Kwachidule:


  • Chiyero:≧99.0%
  • Mulingo Wabwino:Enterprise Standard kapena pakufunika
  • Kuthekera:35Kgs / Mwezi
  • Shelf Life:Zaka zitatu
  • Ntchito:Kuchiza nyamakazi, psoriatic nyamakazi, ankylosing spondylitis ndi ulcerative colitis
  • Ubwino wa Timu:Gulu lazogulitsa zogulitsa kunja ndi maphunziro aukadaulo kufakitale
  • Tsatanetsatane wa Zamalonda

    FAQ

    Zogulitsa Tags

    Zogulitsadzina Tofacitinib Citrate
    Mawu ofanana ndi mawu (3R,4R) -1-(Cyanoacetyl) -4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3 - propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R) -4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
    CAS No. 540737-29-9
    Maonekedwe Kuchokera woyera mpaka woyera ufa
    Molecular Formula C16H20N6OC6H8O7
    Kulemera kwa Maselo 504.50
    Kugwiritsa ntchito Gulu lamankhwala kapena cholinga chofufuza
    Kulongedza Monga mwa pempho lanu
    Kusungirako Sungani m'zotengera zolimba, zosagwira kuwala pamalo ozizira

     

    Tofacitinib Citrate (CAS #540737-29-9)

    ZINTHU

    MFUNDO

    ZOTSATIRA

    Maonekedwe

    Kuchokera woyera mpaka woyera ufa

    Pa ufa woyera

    Chizindikiritso

    HPLC;IR;Mtengo wa HNMR

    Zimagwirizana

    Kusungunuka

    Kusungunuka mu DMSO pa 100mg/ml, kwambiri bwino sungunuka Mowa, mochepa sungunuka m'madzi etc.

    Zimagwirizana

    Kutaya pa Kuyanika

    ≤0.5%

    0.12%

    Zotsalira pakuyatsa

    ≤0.1%

    0.05%

    Zitsulo zolemera

    ≤10ppm

    Zimagwirizana

    Zogwirizana nazo

    Diastereomer (RS+SR) ≤0.1%

    Kusayera Kumodzi ≤0.15%

    Zonyansa zonse ≤1.0%

    0.05%

    0.14%

    0.18%

    Enantiomorphism Isomers

    ≤0.2%

    Zimagwirizana

    Zosungunulira Zotsalira

    Ethanol ≤5000ppm

    Methanol ≤3000ppm

    Toluene ≤890ppm

    Zimagwirizana

    Zinthu za Citrate

    36.2% ~ 40%

    37.8%

    Chiyero

    ≥99.0%

    99.38%

    Kuyesa

    60.68% ~ 63.16% ya Tofacitinib INN

    98% ~ 102% ya Tofacitinib Citrate INN

    62.04%

     

    99.12%

    Kutsiliza: Ikugwirizana

    Zambiri Zamakampani

    √ Kudziwa kwathunthu kwa Management layer mu otsatira fakitale ndi akatswiri aluso;
    √ Quality nthawi zonse timaganizira kwambiri, Olimba QC dongosolo;
    √ zaka 11 zokumana nazo zogulitsa kunja;
    √ Independent R&D labu;
    √ Misonkhano iwiri yosayinidwa yanthawi yayitali ya GMP;
    √ Zida zolemera zamafakitale ambiri opanda pake pazosintha makonda;
    √ Gulu logwira ntchito molimbika kwambiri lomwe lili ndi njira yosasinthika.
    imgsafMtengo wa SDGSHChithunzi cha DASFG

  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife